- Treatment of symptomatic benign prostatic hyperplasia with beta-sitosterol – an 18-month follow-up
- Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia
- Beta-sitosterols for benign prostatic hyperplasia
- A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia
- Beta-sitosterol for the treatment of benign prostatic hyperplasia – a systematic review
Follow Us
